Top Markets
Coin of the day
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.

Claritas Pharmaceuticals, Inc.

CLAZF
Rank in Stocks #42176
Operating as a clinical-stage specialty pharmaceutical entity, Claritas... Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$3.66K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Claritas Pharmaceuticals, Inc. (CLAZF)

Category

Price of CLAZF with the market cap of B
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
CLAZF
$0.0001
Market Capitalization of Claritas Pharmaceuticals, Inc.(CLAZF)
Market Cap: $3.66K
As of August 2026 Claritas Pharmaceuticals, Inc. has a market cap of $3.66K. This makes Claritas Pharmaceuticals, Inc. the world's 42176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Claritas Pharmaceuticals, Inc. from 2016 to 2026
CLAZF compared with Top 5 Most Popular stocks
Price of CLAZF Asset B Mkt. of B Results
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
$147,127 $3.66K
$5.383T +147,126,522,447.14%
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
$120,891 $3.66K
$4.423T +120,890,713,311.81%
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
$113,702 $3.66K
$4.160T +113,702,361,175.81%
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
$100,118 $3.66K
$3.663T +100,118,087,820.20%
Claritas Pharmaceuticals, Inc. Claritas Pharmaceuticals, Inc.
$79,016.91 $3.66K
$2.891T +79,016,911,498.80%